Studies suggest tirzepatide may lead to greater weight loss for some people, but again, this depends on the person and lifestyle changes
The 52-week, phase 3 double-blinded RCT (PIONEER-4) directly compared the glycemic effects and body weight reduction of once-daily oral semaglutide (dose-escalated to 14 mg) and once-daily subcutaneous liraglutide (dose-escalated to 1.8 mg) among 711 T2D participants
These include: AMP-activated protein kinase (AMPK) Upon a reduction in energy, AMPK is activated to stimulate energy producing pathways and turn off energy consuming pathways to restore the ATP/ADP ratio
Prescribers must document clinical eligibility at the time of initial prescribing even retroactively through a central processor rather than through the patient's plan
Buckley et al., "Transcellular stomach absorption of a derivatized GLP-1 receptor agonist," Science Translational Medicine 10(467) (2018)
Pricing depends on dose, pharmacy, and supplies